JP2001275561A - Method for producing fermented milk using yolk liquid containing anti-helicobacter pylori antibody - Google Patents

Method for producing fermented milk using yolk liquid containing anti-helicobacter pylori antibody

Info

Publication number
JP2001275561A
JP2001275561A JP2001048462A JP2001048462A JP2001275561A JP 2001275561 A JP2001275561 A JP 2001275561A JP 2001048462 A JP2001048462 A JP 2001048462A JP 2001048462 A JP2001048462 A JP 2001048462A JP 2001275561 A JP2001275561 A JP 2001275561A
Authority
JP
Japan
Prior art keywords
fermented milk
antibody titer
helicobacter pylori
antibody
yolk liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001048462A
Other languages
Japanese (ja)
Other versions
JP4489315B2 (en
Inventor
Seikun Kin
金聖訓
Teishun Ri
李▲廷▼濬
Kitsusei Kyo
許▲詰▼成
Yeong-Jin Baek
白永振
Teiretsu Ri
李禎烈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HY Co Ltd
Original Assignee
Korea Yakult Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19660718&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2001275561(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Korea Yakult Co Ltd filed Critical Korea Yakult Co Ltd
Publication of JP2001275561A publication Critical patent/JP2001275561A/en
Application granted granted Critical
Publication of JP4489315B2 publication Critical patent/JP4489315B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for producing fermented milk using the subject yolk liquid maintaining anti-Helicobacter pylori antibody titer and intended for preventing general microorganisms and yeast from contamination. SOLUTION: This method for producing fermented milk comprises the following practice: a saccharide is added to a yolk liquid containing anti-Helicobacter pylori antibody to maintain the antibody titer of the resultant yolk liquid followed by conducting a heat sterilization to prevent general microorganisms and yeast from contamination, and the yolk liquid thus sterilized is mixed into a lactic acid bacteria culture solution followed by agitation.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は抗ヘリコバクターピ
ロリ抗体を含有する卵黄液を用いて発酵乳製品を製造す
る際に、抗体の力価を維持するとともに一般の微生物及
び酵母の汚染を防止することができる方法に関する。
The present invention relates to a method for producing fermented milk products using an egg yolk solution containing an anti-Helicobacter pylori antibody, while maintaining the antibody titer and preventing contamination of general microorganisms and yeasts. On how you can.

【0002】[0002]

【従来の技術】最近、胃潰瘍の原因菌として知られてい
るヘリコバクターピロリに対する抗原を産卵鶏に注射
し、この抗原から卵黄に移行した抗体を有効成分として
使用する研究が活発に行われている。日本国特開平4−
275232号は、ヘリコバクターピロリ菌体破砕液を
抗原として生成された抗体を有効成分とする胃潰瘍、十
二指潰瘍の予防食品を開示する。韓国特許公告98−8
1323号は、ヘリコバクターピロリウレアーゼとフラ
ジェラ(鞭毛)に対して免疫化された卵黄抗体を0.0
1〜0.1重量%含有し、乳酸バクテリア、エンテロコ
ッカス(腸球菌)、イースト及びバシラス属のなかから
選択された有機体を含有する胃炎、胃潰瘍及び十二指潰
瘍の予防、治療用の薬学的組成物について開示する。し
かし、前記特許などから作られた卵黄抗体を発酵乳、飲
料などの製品に用いる場合、工程上実施される熱処理に
より特定抗体の力価が著しく減少するため、卵黄抗体に
よる胃潰瘍、胃炎、十二指潰瘍の予防と治療効果を期待
することは難しい。このような卵黄抗体の貯蔵中の力価
維持のための研究としては、シミズなどが、貯蔵又は工
程上抗体の力価維持のため、30〜50重量%の蔗糖又
は砂糖を添加し75〜85℃で15分間熱処理したと報
告している(J.of food science,1
994,59(4),763〜772)。
2. Description of the Related Art Recently, studies have been actively conducted on injecting an antigen against Helicobacter pylori, which is known as a causative agent of gastric ulcer, into laying hens and using an antibody transferred from this antigen to yolk as an active ingredient. Japanese Unexamined Patent Publication No. 4-
No. 275232 discloses a food for preventing gastric ulcer and duodenal ulcer, which contains an antibody produced using a crushed solution of Helicobacter pylori as an antigen as an active ingredient. Korean Patent Publication 98-8
No. 1323 discloses an antibody yolk antibody immunized against Helicobacter pylori urease and flagella (flagellate) at 0.0
Pharmaceutical for preventing and treating gastritis, gastric ulcer and duodenal ulcer containing 1 to 0.1% by weight and containing an organism selected from lactic acid bacteria, enterococcus, yeast and Bacillus sp. A composition is disclosed. However, when the yolk antibody prepared from the above patents is used for products such as fermented milk and beverages, the heat treatment performed in the process significantly reduces the titer of the specific antibody, and thus the stomach ulcer, gastritis, and 12 It is difficult to expect the effect of prevention and treatment of digital ulcer. As a study for maintaining the titer of the yolk antibody during storage, worms and the like added 30 to 50% by weight of sucrose or sugar to maintain the titer of the antibody during storage or process. C. for 15 minutes (J. of food science, 1).
994, 59 (4), 763-772).

【0003】一方、鶏卵の発酵乳に対する適用は、19
84年リンとカニンガムが47.4%の卵白にクエン酸
と28.4%のアルカリ処理大豆油、19.0%の脱脂
乳を殺菌して混合し、これにブドウ糖、蔗糖、キサンタ
ンガム、バニラ抽出物などを添加した後、ラクトバシル
スブルガリカスとストレプトコッカスサーモフィルスを
接種してヨーグルトを開発した。1984年カニンガム
などは、低脂肪均質乳を殺菌、冷却し、これに、54.
4℃で2回殺菌した卵白アルブミンを均質化して混合し
た後、ラクトバシルスブルガリカスとストレプトコッカ
スサーモフィルスを混合、接種し、40℃で6時間培養
してヨーグルトを製造した。また、1983年キムなど
は、58℃、30分の熱処理条件で均質全卵液にブドウ
糖、蔗糖、乳糖を添加し、乳酸菌を添加してpHを4.
8までも低めて発酵乳を製造した。日本国の場合、特許
公告(公告番号:昭57−54113)には、卵白のリ
ゾチームを除去した乾燥滅菌卵白を牛乳に溶解し、ブド
ウ糖を添加した後、乳酸菌を接種して発酵乳を製造する
という技術が開示されている。韓国の特許としては、ユ
など(公告番号:97−574)が全卵液、卵黄液、卵
白液に乳糖、砂糖、水を混合し殺菌した後、ラクトバシ
ルスアシドフィルス、ビフィドバクテリウムロンガム、
ストレプトコッカスサーモフィルスを混合、接種して発
酵させる乳酸菌発酵飲料の製造方法を開示した。以上の
ように、鶏卵を用いる発酵乳の開発は、全卵液、卵白、
卵黄の希釈液に、発酵を促進させるための糖、アルカリ
処理大豆乳、脱脂乳などを混合して発酵乳を製造し、発
酵乳の層分離現象など、物理的安定性を解決するため、
キサンタンガムのような安定剤を使用した。
On the other hand, application of chicken eggs to fermented milk is 19
1984 Phosphorus and Cunningham are sterilized and mixed with 47.4% egg white, citric acid, 28.4% alkali-treated soybean oil, and 19.0% skim milk, and then extracted with glucose, sucrose, xanthan gum and vanilla. After adding the ingredients, Lactobacillus bulgaricus and Streptococcus thermophilus were inoculated to develop yogurt. In 1984 Cunningham et al. Sterilized and cooled low-fat homogenous milk,
After homogenizing and mixing ovalbumin sterilized twice at 4 ° C., Lactobacillus bulgaricus and Streptococcus thermophilus were mixed, inoculated, and cultured at 40 ° C. for 6 hours to produce yogurt. In 1983, Kim et al. Added glucose, sucrose, and lactose to a homogeneous whole egg solution under a heat treatment condition of 58 ° C. for 30 minutes, and added lactic acid bacteria to adjust the pH to 4.
The fermented milk was produced by lowering it to as low as 8. In the case of Japan, a patent publication (publication number: 57-54113) discloses that dried and sterilized egg white from which egg white lysozyme has been removed is dissolved in milk, glucose is added, and lactic acid bacteria are inoculated to produce fermented milk. Is disclosed. As a Korean patent, Yu et al. (Publication number: 97-574) is prepared by mixing lactose, sugar, and water with whole egg solution, egg yolk solution, and egg white solution, sterilizing the mixture, and then lactobacillus acidophilus, bifidobacterium longum. ,
A method for producing a lactic acid bacteria fermented beverage that is mixed, inoculated, and fermented with Streptococcus thermophilus has been disclosed. As mentioned above, the development of fermented milk using chicken eggs is whole egg solution, egg white,
To dilute the egg yolk, sugar to promote fermentation, alkali-treated soy milk, skim milk, etc. to produce fermented milk, to resolve the physical stability, such as the layer separation phenomenon of fermented milk,
A stabilizer such as xanthan gum was used.

【0004】[0004]

【発明が解決しようとする課題】本発明は鶏卵の希釈液
に乳酸菌成長促進物質を添加した後、乳酸菌を接種して
培養する従来の技術とは異なり、既存の発酵乳工程に、
抗ヘリコバクターピロリ抗体を含有する卵黄液を添加す
る方法に関し、より詳細には発酵乳の製造工程におい
て、抗ヘリコバクターピロリ抗体力価を維持するのみな
く、一般の微生物及び酵母の汚染も防止するための殺菌
方法を提供しようとするものである。
The present invention is different from the conventional technique of adding a lactic acid bacterium growth promoting substance to a diluted solution of chicken eggs and then inoculating lactic acid bacteria and culturing the same.
The present invention relates to a method of adding an egg yolk solution containing an anti-Helicobacter pylori antibody, and more particularly, in the process of producing fermented milk, not only to maintain the anti-Helicobacter pylori antibody titer but also to prevent contamination of general microorganisms and yeast. It is intended to provide a sterilization method.

【0005】すなわち、本発明は、ヘリコバクターピロ
リ抗原により免疫化された卵黄抗体を含む卵黄液を発酵
乳の製造に適用するに際し、これらが持っている抗体力
価を維持するとともに一般の微生物及び酵母の汚染を防
止することができる殺菌方法を提供することを目的とす
る。
That is, the present invention is intended to maintain the antibody titer of the yolk solution containing the yolk antibody immunized with the Helicobacter pylori antigen in the production of fermented milk, maintain the antibody titer of the yolk solution, and generally use microorganisms and yeasts. It is an object of the present invention to provide a sterilization method capable of preventing the contamination of water.

【0006】[0006]

【課題を解決するための手段】本発明者らはヘリコバク
ターピロリを抗原として、産卵鶏から抗体の入っている
免疫卵を生産した。こうして生産された免疫卵から抗体
を含有している卵黄部分のみを分離して発酵乳の製造に
使用しようとした。そして、卵黄液を発酵乳製品に添加
するに際し、一般の微生物と酵母の汚染を防止し、熱処
理過程で抗体力価の減少を防止するための殺菌条件を研
究して本発明を完成することになった。
Means for Solving the Problems The present inventors produced immunized eggs containing antibodies from laying hens using Helicobacter pylori as an antigen. An attempt was made to separate only the yolk portion containing the antibody from the immunized egg thus produced and use it for the production of fermented milk. Then, upon adding the egg yolk liquid to the fermented milk product, to prevent contamination of general microorganisms and yeast, to study sterilization conditions to prevent a decrease in antibody titer during the heat treatment process, to complete the present invention. became.

【0007】[0007]

【発明の実施の形態】本発明の望ましい一実施例による
と、抗ヘリコバクターピロリ抗体を含有する卵黄液に糖
を添加して抗体力価を維持し、殺菌熱処理して一般の微
生物及び酵母の汚染を防止した後、この殺菌処理された
卵黄液を乳酸菌培養液に混合し撹拌することで発酵乳を
製造する。抗体力価を維持するために使用する望ましい
糖は砂糖、高果糖、ガラクトオリゴ糖からなる群から選
択されるが、より望ましくは砂糖である。
DETAILED DESCRIPTION OF THE INVENTION According to a preferred embodiment of the present invention, a sugar is added to an egg yolk solution containing an anti-Helicobacter pylori antibody to maintain an antibody titer, and sterilization heat treatment is performed to contaminate general microorganisms and yeast. Then, the sterilized egg yolk liquid is mixed with a lactic acid bacteria culture and stirred to produce fermented milk. The preferred sugar used to maintain the antibody titer is selected from the group consisting of sugar, high fructose, and galactooligosaccharides, but is more preferably sugar.

【0008】前記卵黄液に添加される糖の含量は重量比
10〜30%が望ましい。また、前記殺菌熱処理は、6
0〜65℃で2〜10分間1〜3回にわたり行われるこ
とが望ましい。
[0008] The content of sugar added to the egg yolk solution is preferably 10 to 30% by weight. In addition, the sterilization heat treatment is performed by 6
Desirably, the reaction is performed 1 to 3 times at 0 to 65 ° C for 2 to 10 minutes.

【0009】本発明の望ましい実施例によると、前記乳
酸菌培養液に添加される熱処理された卵黄液の含量は重
量比で0.1〜10%である。
According to a preferred embodiment of the present invention, the content of the heat-treated egg yolk liquid added to the lactic acid bacteria culture solution is 0.1 to 10% by weight.

【0010】抗原の準備 胃潰瘍の原因菌として知られたヘリコバクターピロリを
超音波で破砕した後、遠心分離して上澄み液を得た。こ
の上澄み液を超遠心分離して細胞膜を沈殿させた後、蒸
留水に懸濁させて抗原として使用した(実施例1参
照)。
Preparation of Antigen Helicobacter pylori, which is known as a causative bacterium of gastric ulcer, was disrupted by ultrasonic waves and centrifuged to obtain a supernatant. The supernatant was ultracentrifuged to precipitate a cell membrane, and then suspended in distilled water and used as an antigen (see Example 1).

【0011】抗ヘリコバクターピロリ抗体を含有する卵
黄液の製造 外膜蛋白質抗原を用いて40週齢の白色レグホンに免疫
を実施した。アジュバント、乳化剤、抗原を9:1:8
の割合で混合して乳化した後、十分な抗体が得られるま
で2週間隔で4回にわたって筋肉注射を行った。鶏卵に
移行した特異的抗体力価が十分に上昇した段階の鶏卵を
収集した。収集した免疫卵を割卵基を経て卵白と卵黄に
分離し、分離した卵黄をフィルタで濾過した後、70〜
80kg/cm2に均質化させて卵黄液を製造した。こ
うして製造された卵黄液の抗ヘリコバクターピロリ抗体
力価はおよそ5,700程度であった(実施例2、3参
照)。
Production of Egg Yolk Solution Containing Anti-Helicobacter pylori Antibody A 40-week-old white leghorn was immunized using an outer membrane protein antigen. 9: 1: 8 adjuvant, emulsifier, antigen
After emulsification by mixing at a ratio of 1%, intramuscular injections were performed four times at two-week intervals until sufficient antibodies were obtained. Eggs at the stage where the specific antibody titer transferred to the eggs was sufficiently increased were collected. The collected immunized eggs are separated into albumen and yolk via a cleavage ovum, and the separated yolk is filtered with a filter.
Egg yolk fluid was produced by homogenizing to 80 kg / cm2. The anti-Helicobacter pylori antibody titer of the yolk fluid thus produced was about 5,700 (see Examples 2 and 3).

【0012】糖濃度と殺菌温度による抗体力価 卵黄液の貯蔵性を高め、抗体力価の減少を防止するた
め、砂糖の濃度と殺菌濃度による抗体力価の変化を確認
した。その結果、10重量%の砂糖濃度を有する卵黄液
を63℃以下の殺菌温度で10分間処理すると抗ヘリコ
バクターピロリ抗体力価を80%以上に維持し得ること
が示された(実施例4参照)。
Antibody titer depending on sugar concentration and sterilization temperature Changes in antibody titer due to sugar concentration and sterilization concentration were confirmed in order to enhance the storage stability of egg yolk fluid and prevent a decrease in antibody titer. As a result, it was shown that the anti-Helicobacter pylori antibody titer can be maintained at 80% or more when the yolk liquid having a sugar concentration of 10% by weight is treated at a sterilization temperature of 63 ° C. or less for 10 minutes (see Example 4). .

【0013】殺菌時間による抗体力価及び汚染度 特に、砂糖を10%添加した卵黄液を63℃で3、5、
7、10分間それぞれ殺菌した後、抗ヘリコバクターピ
ロリ抗体力価と一般の微生物及び酵母汚染度を測定し
た。その結果、63℃で5分間まで熱処理した場合、抗
体力価が90%以上維持されることが示され、汚染度の
測定結果、7分以上の熱処理だけで、一般の微生物と酵
母が完全に死滅することを確認することができた(実施
例5参照)。
Antibody titer and degree of contamination by sterilization time Particularly, the yolk solution to which sugar was added at 10% was added at 63 ° C. for 3, 5,
After sterilization for 7, 10 minutes, the anti-Helicobacter pylori antibody titer and the degree of contamination of general microorganisms and yeast were measured. As a result, when heat treatment was performed at 63 ° C. for 5 minutes, it was shown that the antibody titer was maintained at 90% or more. As a result of the measurement of the degree of contamination, general microorganisms and yeasts were completely removed only by heat treatment for 7 minutes or more. It was confirmed that the cells died (see Example 5).

【0014】殺菌回数による抗体力価及び汚染度 砂糖を10%添加した卵黄液を63℃、3分の熱処理条
件で3回にわたって殺菌しながら抗体力価の変化と汚染
度を確認した。その結果、抗ヘリコバクターピロリ抗体
力価は2回殺菌するまで95%以上維持され、一般の微
生物と酵母の汚染度も2回の殺菌時、殆ど抑制されるこ
とが示された。したがって、卵黄液の抗体力価を維持す
るとともに微生物の汚染を防止するためには、63℃で
3分ずつ2回にわたって殺菌することがより効果的であ
ることを確認した(実施例6参照)。
Antibody Titer and Degree of Contamination According to the Number of Sterilizations The yolk liquid to which 10% of sugar was added was sterilized three times under a heat treatment condition of 63 ° C. for 3 minutes, and the change in the antibody titer and the degree of contamination were confirmed. As a result, it was shown that the anti-Helicobacter pylori antibody titer was maintained at 95% or more until sterilized twice, and the degree of contamination of general microorganisms and yeast was almost suppressed when sterilized twice. Therefore, in order to maintain the antibody titer of the yolk fluid and to prevent microbial contamination, it was confirmed that it was more effective to sterilize twice at 63 ° C. for 3 minutes (see Example 6). .

【0015】卵黄液を用いる発酵乳の製造 抗ヘリコバクターピロリ抗体を含有する卵黄液を用いて
発酵乳を製造した。殺菌された原料乳にラクトバシルス
アシドフィルスカセイ、ストレプトコッカスサーモフィ
ルス、ビフィドバクテリウムロンガムを一定の濃度で接
種し、pH4.5になるまで培養した後、冷却させた。
そして、果汁濃縮液、食餌繊維、ブドウ糖、オリゴ糖な
どを溶かしてシロップを製造した。特に、卵黄液を63
℃で3分間2回殺菌処理し、0.1〜10重量%を前記
培養液に混合して撹拌した。これに、予め製造されたシ
ロップを一定の割合で混合、撹拌して均質化した後、容
器に包装した。こうして特定抗体を有効成分として含有
している卵黄が添加された発酵乳を官能検査した結果、
風味、物性、全体的な味において良好な結果を示した
(実施例7参照)。
Production of Fermented Milk Using Egg Yolk Fermented milk was produced using an egg yolk liquid containing an anti-Helicobacter pylori antibody. Lactobacillus acidophilus scabii, Streptococcus thermophilus, and Bifidobacterium longum were inoculated to the sterilized raw milk at a constant concentration, cultured until the pH reached 4.5, and then cooled.
Then, a syrup was produced by dissolving the juice concentrate, dietary fiber, glucose, oligosaccharide, and the like. In particular, 63
The mixture was sterilized twice at 3 ° C. for 3 minutes, and 0.1 to 10% by weight was mixed with the culture solution and stirred. The syrup prepared in advance was mixed at a predetermined ratio, stirred and homogenized, and then packaged in a container. As a result of a sensory test of fermented milk to which egg yolk containing a specific antibody as an active ingredient was added,
Good results were shown in flavor, physical properties and overall taste (see Example 7).

【0016】以下、実施例に基づいて本発明をより詳細
に説明する。しかし、以下の実施例は本発明の範囲を限
定するものではなく、本発明の技術的思想の範囲内で当
業者による通常の変形が可能である。
Hereinafter, the present invention will be described in more detail with reference to examples. However, the following examples do not limit the scope of the present invention, and ordinary modifications can be made by those skilled in the art within the technical idea of the present invention.

【0017】実施例1 抗原の準備 ヘリコバクターピロリを5%の馬血清を含有するブルセ
ラ培地で37℃、2日間培養した。この培養液を4,0
00×gで遠心分離して菌体を回収した後、リン酸緩衝
生理食塩水に懸濁させた。超音波で菌体を破砕した後、
10,000×gで20分間遠心分離して、破砕されて
いない菌体を除去した後、回収した上澄み液を100,
000×gで30分間超遠心分離して細胞膜を沈殿させ
た後、蒸留水に懸濁させて抗原として使用した。
Example 1 Preparation of Antigen Helicobacter pylori was cultured at 37 ° C. for 2 days in a Brucella medium containing 5% horse serum. This culture was added to 4,0
After the cells were collected by centrifugation at 00 × g, they were suspended in phosphate buffered saline. After crushing the cells with ultrasound,
After centrifugation at 10,000 × g for 20 minutes to remove unbroken cells, the collected supernatant was added to 100,100 g
After ultracentrifugation at 000 × g for 30 minutes to precipitate cell membranes, the cells were suspended in distilled water and used as antigens.

【0018】実施例2 抗ヘリコバクターピロリ抗体の製造 実施例1で製造した外膜蛋白質抗原を用いて白色レグホ
ンに免疫を実施した。アジュバントはミネラルオイルの
一種であるドラケオール(Drakeol)と乳化剤を
混合して使用し、乳化剤としてはスパン85(Span
85)及びトゥイーン85(Tween 85)を5
4:46の割合で混合して使用した。ドラケオール、乳
化剤、抗原を9:1:8の割合で混合して乳化させた
後、十分な抗体力価が得られるまで2週間隔で4回にわ
たって筋肉注射を行った。鶏卵に移行した特異的抗体力
価の推移を追跡して、抗体力価が十分に上昇した段階の
鶏卵を採取して卵黄液を製造した。
Example 2 Production of Anti-Helicobacter pylori Antibody White legphone was immunized using the outer membrane protein antigen produced in Example 1. The adjuvant is a mixture of Drakeol, a kind of mineral oil, and an emulsifier, and the emulsifier is Span 85 (Span
85) and Tween 85
The mixture was used in a ratio of 4:46. After mixing and emulsifying drakeol, an emulsifier, and an antigen in a ratio of 9: 1: 8, intramuscular injection was performed four times at two-week intervals until a sufficient antibody titer was obtained. The transition of the specific antibody titer transferred to the egg was tracked, and the egg at the stage where the antibody titer was sufficiently increased was collected to produce an egg yolk solution.

【0019】間隔を置き4回にわたって筋肉注射を行っ
た。鶏卵に移行した特異的抗体力価が十分に上昇した段
階の鶏卵を収集した。収集した免疫卵を割卵基を経て卵
白と卵黄に分離し、分離した卵黄をフィルタで濾過した
後、70〜80kg/cm2で均質化して卵黄液を製造
した。
Four intramuscular injections were made at intervals. Eggs at the stage where the specific antibody titer transferred to the eggs was sufficiently increased were collected. The collected immunized eggs were separated into egg whites and yolks via a cleavage ovum, and the separated yolks were filtered with a filter, and then homogenized at 70 to 80 kg / cm2 to produce an egg yolk solution.

【0020】実施例3 抗体力価の測定 卵黄中の抗ヘリコバクターピロリ抗体力価はマイクロタ
イター法によりつぎのように測定した。卵黄液1gとラ
ムダカラゲナン水溶液(0.15%w/v)9mlを混
合し、室温で30分間放置した後、10,000×g、
10分間遠心分離を行うことで、特異的抗体を含有する
卵黄水溶性蛋白分画を得て試料液とした。試料液をリン
酸緩衝液(PBS、pH7.4)で2n倍希釈して検液
とした。凝集抗体力価は、各検液50μlと菌破砕液5
0μlをμプレートに混合した後、37℃で24時間定
置して凝集の有無を調査することにより得られた。抗体
力価は凝集が現れるサンプルの最大希釈倍率の逆数で示
された。実施例2により製造された卵黄液の抗体力価は
およそ5,700程度と示された。
Example 3 Measurement of Antibody Titer Anti-Helicobacter pylori antibody titer in egg yolk was measured by the microtiter method as follows. After mixing 1 g of egg yolk solution and 9 ml of an aqueous solution of lambda carrageenan (0.15% w / v), and allowed to stand at room temperature for 30 minutes, 10,000 × g,
By centrifuging for 10 minutes, a yolk water-soluble protein fraction containing a specific antibody was obtained and used as a sample solution. The sample solution was diluted 2 n-fold with a phosphate buffer (PBS, pH 7.4) to obtain a test solution. The agglutinating antibody titer was 50 μl of each test solution and 5 μl
After mixing 0 μl with the μ plate, the mixture was left at 37 ° C. for 24 hours to examine the presence or absence of aggregation. Antibody titers were expressed as the reciprocal of the highest dilution of the sample where aggregation appeared. The antibody titer of the yolk fluid produced according to Example 2 was shown to be about 5,700.

【0021】実施例4 糖濃度と殺菌温度による抗体力価 卵黄液の貯蔵性を高めるためには、殺菌工程が必須であ
る。しかし、この殺菌工程の熱処理条件により抗体力価
が減少する。従って、殺菌工程による抗体力価の減少を
防止するため、砂糖をいろいろの濃度で添加した後、殺
菌温度による抗体力価の変化を次のように確認した。ま
ず卵黄液に砂糖を0、10、20、30、40重量%の
濃度で添加し、それぞれの卵黄液を管形殺菌器を用いて
60、63、65、67℃で10分間殺菌処理を行っ
た。殺菌処理後、実施例3の方法により抗体力価の変化
を確認した。
Example 4 Antibody titer based on sugar concentration and sterilization temperature In order to enhance the storage ability of egg yolk fluid, a sterilization step is essential. However, the heat treatment conditions of this sterilization step reduce the antibody titer. Therefore, in order to prevent the antibody titer from decreasing due to the sterilization process, after adding sugar at various concentrations, the change in the antibody titer due to the sterilization temperature was confirmed as follows. First, sugar is added to the yolk solution at a concentration of 0, 10, 20, 30, or 40% by weight, and each of the yolk solutions is sterilized at 60, 63, 65, or 67 ° C. for 10 minutes using a tubular sterilizer. Was. After the sterilization treatment, a change in the antibody titer was confirmed by the method of Example 3.

【0022】図1に示すように、10重量%以上の砂糖
を卵黄液に添加し、63℃以下の殺菌温度で処理する場
合、抗体力価がおよそ80%以上で維持されることが示
された。
As shown in FIG. 1, when 10% by weight or more of sugar is added to the egg yolk solution and treated at a sterilizing temperature of 63 ° C. or less, the antibody titer is maintained at about 80% or more. Was.

【0023】実施例5 殺菌時間による抗体力価及び汚染度 実施例5で設定された63℃で、殺菌時間による抗体力
価と一般の微生物及び酵母の汚染度を確認した。まず卵
黄液を63℃で3、5、7、10分間それぞれ殺菌した
後、実施例3の方法により抗体力価を測定した。同時
に、殺菌時間別試料1mlを取り、10進連続希釈し
た。希釈液1mlをペトリ皿に接種し、PCA(pla
te count agar,Difco,#0479
−17−6)培地を分株して固めた後、37℃で2日間
培養した結果、現れた集落数を一般の微生物で計数し
た。そして、希釈液1mlをペトリ皿に接種してPDA
(potato dextrose agar,Dif
co,#0013−17−6)培地を分株し、25℃で
4日間培養した結果、現れた集落数を酵母数で計数し
た。
Example 5 Antibody Titer and Degree of Contamination by Sterilization Time At 63 ° C. set in Example 5, the antibody titer and the degree of contamination of general microorganisms and yeast by the sterilization time were confirmed. First, the yolk fluid was sterilized at 63 ° C. for 3, 5, 7, and 10 minutes, respectively, and then the antibody titer was measured by the method of Example 3. At the same time, 1 ml samples were taken at different sterilization times and serially diluted in decimal. 1 ml of the diluted solution was inoculated into a Petri dish, and PCA (pla
te count agar, Difco, # 0479
-17-6) After separating and consolidating the medium, the medium was cultured at 37 ° C. for 2 days. As a result, the number of colonies that appeared was counted using general microorganisms. Then, inoculate 1 ml of the diluted solution into a Petri dish and PDA
(Potato dextrose agar, Dif
co, # 0013-17-6) The medium was separated and cultured at 25 ° C. for 4 days. The number of colonies that appeared was counted by the number of yeasts.

【0024】図2に示すように、63℃で5分間まで熱
処理した場合、抗ヘリコバクターピロリ抗体の力価は9
0%以上で維持されることが示された。しかし、汚染度
の測定結果、7分以上の熱処理のみによって一般の微生
物と酵母が完全に死滅することが確認できた。
As shown in FIG. 2, the anti-Helicobacter pylori antibody had a titer of 9 when heat-treated at 63 ° C. for up to 5 minutes.
It was shown to be maintained above 0%. However, as a result of the measurement of the degree of contamination, it was confirmed that general microorganisms and yeasts were completely killed only by heat treatment for 7 minutes or more.

【0025】実施例6 殺菌回数による抗体力価及び汚染度 実施例5では抗体力価が維持される殺菌条件が63℃、
5分と示されたが、この殺菌条件では一般の微生物と酵
母の汚染を防止することができないため、殺菌回数を増
やす方案を検討した。10重量%の砂糖が添加された卵
黄液を63℃、3分の熱処理条件で3回まで殺菌しなが
ら抗体力価の変化と汚染度を確認した。図3に示すよう
に、抗体力価の維持は2回殺菌時までそのまま維持さ
れ、一般の微生物と酵母の汚染度も2回殺菌時に殆ど抑
制されることが示された。したがって、卵黄液の抗体力
価を維持するとともに微生物の汚染を防止するために
は、63℃で続けて熱処理するよりは、3分ずつ2回に
わたって殺菌することがより効果的であることを確認し
た。
Example 6 Antibody titer and degree of contamination depending on the number of sterilizations In Example 5, the sterilization conditions for maintaining the antibody titer were 63 ° C.
Although it was indicated as 5 minutes, under these sterilizing conditions, contamination of general microorganisms and yeast could not be prevented, so a method of increasing the number of sterilizations was examined. The egg yolk solution to which 10% by weight of sugar was added was sterilized up to three times under a heat treatment condition of 63 ° C. for 3 minutes, and the change in antibody titer and the degree of contamination were confirmed. As shown in FIG. 3, it was shown that the maintenance of the antibody titer was maintained as it was until the second sterilization, and the degree of contamination of general microorganisms and yeast was almost suppressed during the second sterilization. Therefore, in order to maintain the antibody titer of the yolk fluid and prevent microbial contamination, it was confirmed that it is more effective to sterilize twice for 3 minutes each time than to continuously heat-treat at 63 ° C. did.

【0026】実施例7 卵黄液を用いる発酵乳の製造 抗ヘリコバクターピロリ抗体を含有する卵黄液を用い
て、図4のように、発酵乳を製造した。まず脱脂粉乳を
用いて無脂乳固形分含量を8〜20重量%に調整した原
料乳を72〜75℃で15秒間殺菌した。殺菌された原
料乳を一定の温度まで冷却した後、ラクトバシルスアシ
ドフィルスとラクトバシルスカセイ、ストレプトコッカ
スサーモフィルス、ビフィドバクテリウムロンガムを1
06cfu/mlの濃度で接種してpHが4.5となる
まで培養してから冷却した。次いで、果汁濃縮液0.1
〜50重量%、食餌繊維0.1〜20重量%、ブドウ糖
0.5〜30重量%、オリゴ糖0.1〜15重量%など
を溶かしてシロップを製造した。こうして製造したシロ
ップを殺菌した後、冷却した。一方、10重量%の砂糖
を添加し63℃で3分間2回殺菌処理した卵黄液0.1
〜10重量%を前記乳酸菌培養液に混合し撹拌した。こ
れに、予め製造されたシロップを一定の割合で混合、撹
拌して均質化させた後、容器に包装した。このように、
特定抗体を有効成分として含有している卵黄が添加され
た発酵乳を官能検査した結果、風味、物性、全体的な味
において良好な結果が示された。
Example 7 Production of Fermented Milk Using Egg Yolk Liquid Fermented milk was produced as shown in FIG. 4 using an egg yolk liquid containing an anti-Helicobacter pylori antibody. First, raw milk adjusted to a non-fat milk solid content of 8 to 20% by weight using skim milk powder was sterilized at 72 to 75 ° C for 15 seconds. After cooling the sterilized raw milk to a certain temperature, 1 part of Lactobacillus acidophilus, Lactobacillus scabii, Streptococcus thermophilus and Bifidobacterium longum are added.
The cells were inoculated at a concentration of 06 cfu / ml, cultured until the pH reached 4.5, and then cooled. Then, the juice concentrate 0.1
5050% by weight, dietary fiber 0.1-20% by weight, glucose 0.5-30% by weight, oligosaccharide 0.1-15% by weight, etc. were dissolved to prepare a syrup. The syrup thus produced was sterilized and cooled. On the other hand, 10% by weight of sugar was added and the yolk liquid 0.1 sterilized twice at 63 ° C. for 3 minutes.
Was mixed with the lactic acid bacteria culture solution and stirred. The syrup prepared in advance was mixed and stirred at a predetermined ratio, homogenized, and then packaged in a container. in this way,
As a result of a sensory test of fermented milk to which egg yolk containing a specific antibody as an active ingredient was added, favorable results were shown in flavor, physical properties, and overall taste.

【0027】[0027]

【発明の効果】以上の実施例から確認したように、本発
明による卵黄液の熱処理工程は、抗ヘリコバクターピロ
リ抗体力価がそのまま維持されるとともに、一般の微生
物と酵母の汚染を抑制することができた。したがって、
本発明によると、抗ヘリコバクターピロリ抗体力価を維
持している卵黄液を用いて発酵乳を製造することができ
る。
As has been confirmed from the above examples, the heat treatment step of the yolk liquid according to the present invention can maintain the anti-Helicobacter pylori antibody titer as it is and suppress the contamination of general microorganisms and yeast. did it. Therefore,
ADVANTAGE OF THE INVENTION According to this invention, fermented milk can be manufactured using the yolk liquid which maintains anti- Helicobacter pylori antibody titer.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 糖濃度と殺菌温度による抗体力価の変化を示
すグラフ
FIG. 1 is a graph showing changes in antibody titer according to sugar concentration and sterilization temperature.

【図2】 殺菌時間による抗体力価と微生物汚染度の変
化を示すグラフ
FIG. 2 is a graph showing changes in antibody titer and microbial contamination with time of sterilization.

【図3】 殺菌回数による抗体力価と微生物汚染度の変
化を示すグラフ
FIG. 3 is a graph showing changes in antibody titer and microbial contamination with the number of sterilizations.

【図4】 抗ヘリコバクターピロリ抗体を含有する卵黄
液を用いる発酵乳の製造工程図
FIG. 4 is a production process diagram of fermented milk using an egg yolk solution containing an anti-Helicobacter pylori antibody.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 許▲詰▼成 大韓民国 忠清南道 天安市 新富洞 大 林ハンスプアパート 304−305 (72)発明者 白永振 大韓民国 ソウル市 瑞草区 瑞草3洞 1481−14 賢英ビラ ガ洞 302 (72)発明者 李禎烈 大韓民国 京畿道 安養市 東安區 平村 洞 草原マウル 大原アパート 302−904 Fターム(参考) 4B001 AC02 AC03 AC09 AC31 BC14 EC05 4B018 LB07 LE04 MD30 MD31 MD71 MD72 ME09 MF13  ────────────────────────────────────────────────── ─── Continuing on the front page (72) Inventor Xu-Zu ▼ Cheng South Korea Chungcheongnam-do, Cheonan-si, Shinbuk-dong, Obayashi Hansparp 304-305 (72) Inventor Shiranaga, South Korea Seocho-gu, Seoul Seocho-gu, Seoul 1481 −14 Kenei-Biraga-dong 302 (72) Inventor Li-jeong-ri South Korea, Gyeonggi-do, Anyang-si, Dong-An-gu, Pyeongchon-dong, Prairie-Maul, Ohara Apartment 302-904 F-term (reference) 4B001 AC02 AC03 AC09 AC31 BC14 EC05 4B018 LB07 LE04 MD30 MD31 MD71 MD72 ME09 MF13

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 発酵乳の製造において、抗ヘリコバクタ
ーピロリ抗体を含有する卵黄液に糖を添加して抗体力価
を維持し、殺菌熱処理して一般の微生物及び酵母の汚染
を防止した後、この殺菌処理された卵黄液を乳酸菌培養
液に混合して撹拌することを特徴とする発酵乳の製造方
法。
In the production of fermented milk, sugar is added to an egg yolk solution containing an anti-Helicobacter pylori antibody to maintain the antibody titer, and sterilization heat treatment is performed to prevent contamination of general microorganisms and yeast. A method for producing fermented milk, comprising mixing a sterilized egg yolk solution with a lactic acid bacteria culture solution and stirring the mixture.
【請求項2】 前記糖が、砂糖、高果糖、ガラクトオリ
ゴ糖からなる群から選択されることを特徴とする請求項
1記載の発酵乳の製造方法。
2. The method for producing fermented milk according to claim 1, wherein the sugar is selected from the group consisting of sugar, high fructose, and galactooligosaccharide.
【請求項3】 前記卵黄液に添加される糖の含量が重量
比で10〜30%であることを特徴とする請求項1又は
2記載の発酵乳の製造方法。
3. The method for producing fermented milk according to claim 1, wherein the content of sugar added to the egg yolk liquid is 10 to 30% by weight.
【請求項4】 前記殺菌熱処理が60〜65℃で2〜1
0分間1〜3回にわたって行われることを特徴とする請
求項1記載の発酵乳の製造方法。
4. The method according to claim 1, wherein the sterilizing heat treatment is carried out at 60 to 65 ° C. for 2 to 1
2. The method for producing fermented milk according to claim 1, wherein the fermented milk is performed 1 to 3 times for 0 minutes.
【請求項5】 前記乳酸菌培養液に添加される熱処理さ
れた卵黄液の含量が重量比で0.1〜10%であること
を特徴とする請求項1記載の発酵乳の製造方法。
5. The method for producing fermented milk according to claim 1, wherein the content of the heat-treated egg yolk liquid added to the lactic acid bacteria culture solution is 0.1 to 10% by weight.
JP2001048462A 2000-03-31 2001-02-23 Method for producing fermented milk using egg yolk liquid containing anti-Helicobacter pylori antibody Expired - Lifetime JP4489315B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020000016916A KR100366302B1 (en) 2000-03-31 2000-03-31 A METHOD OF PREPARING FERMENTED MILK USING EGG YOLK CONTAINING ANTI-Helicobacter pylori CHICKEN IgY
KR2000-16916 2000-03-31

Publications (2)

Publication Number Publication Date
JP2001275561A true JP2001275561A (en) 2001-10-09
JP4489315B2 JP4489315B2 (en) 2010-06-23

Family

ID=19660718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001048462A Expired - Lifetime JP4489315B2 (en) 2000-03-31 2001-02-23 Method for producing fermented milk using egg yolk liquid containing anti-Helicobacter pylori antibody

Country Status (2)

Country Link
JP (1) JP4489315B2 (en)
KR (1) KR100366302B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100403282B1 (en) * 2001-06-29 2003-10-30 주식회사 에그 바이오택 The formulation for production of IgY products containing anti-Helicobacter pylori and anti-E.coli IgY, aloe powder, green tee extracts powder, and perilla powder to inhibit the growth of Helicobacter pylori
KR100542484B1 (en) * 2001-12-28 2006-01-16 주식회사 에그 바이오택 THE PRODUCTION METHOD OF EGG CONTAINING IgY ABOUT ETEC, Salmonella enteritidis, Salmonella typhimurium, Helicobacter pylori AND THEREOF ICE CREAM OR YOGHURT EGG YOLK, EGG YOLK POWDER AND MIXING IgY POWDER WHICH IS EXTRACTED ABOVE EGG
JP2006014654A (en) * 2004-07-01 2006-01-19 Asama Chemical Co Ltd Antibody-containing food
JP2007053930A (en) * 2005-08-23 2007-03-08 Asama Chemical Co Ltd Method for producing antibody-containing fermented food

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020021545A (en) * 2000-09-15 2002-03-21 이은선 FERMENTED MILK, MILK, ICECREAM USING EGG YOLK HAVING IgY, AND ITS METHOD FOR PREPARING
KR100392904B1 (en) * 2001-01-12 2003-07-28 매일유업주식회사 Composition containing egg yolk antibody, and food containing it
KR20020093410A (en) * 2001-06-08 2002-12-16 (주)두솔 Functional silken tofu and method for preparing thereof
KR100785666B1 (en) * 2001-08-01 2007-12-14 농업회사법인 오보바이오 주식회사 Functional pudding and method for preparing thereof
KR20030012560A (en) * 2001-08-01 2003-02-12 주식회사 리앤조바이오텍 Functional soybean milk and method for preparing thereof
KR100485269B1 (en) * 2002-10-22 2005-04-29 주식회사 에그 바이오택 The production method of kimchi containing immunoglobulin y for e.coli, helicobacter pylori and thereof kimchi
KR101024297B1 (en) * 2010-08-11 2011-03-29 유익종 Egg with reduced antigenicity of egg proteins by sodium lactate, heat treatment and lactic acid fermentation and producing method for the same
CN106465749B (en) * 2015-08-14 2019-11-08 内蒙古伊利实业集团股份有限公司 A kind of acidified milk and preparation method thereof containing egg yolk liquid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100403282B1 (en) * 2001-06-29 2003-10-30 주식회사 에그 바이오택 The formulation for production of IgY products containing anti-Helicobacter pylori and anti-E.coli IgY, aloe powder, green tee extracts powder, and perilla powder to inhibit the growth of Helicobacter pylori
KR100542484B1 (en) * 2001-12-28 2006-01-16 주식회사 에그 바이오택 THE PRODUCTION METHOD OF EGG CONTAINING IgY ABOUT ETEC, Salmonella enteritidis, Salmonella typhimurium, Helicobacter pylori AND THEREOF ICE CREAM OR YOGHURT EGG YOLK, EGG YOLK POWDER AND MIXING IgY POWDER WHICH IS EXTRACTED ABOVE EGG
JP2006014654A (en) * 2004-07-01 2006-01-19 Asama Chemical Co Ltd Antibody-containing food
JP2007053930A (en) * 2005-08-23 2007-03-08 Asama Chemical Co Ltd Method for producing antibody-containing fermented food

Also Published As

Publication number Publication date
KR100366302B1 (en) 2003-01-09
KR20000049499A (en) 2000-08-05
JP4489315B2 (en) 2010-06-23

Similar Documents

Publication Publication Date Title
US20200397837A1 (en) Activated bifidobacteria and methods of use thereof
US6491956B2 (en) Food containing active strains for inhibiting infection and treating gastritis, gastric and duodenal ulcers
Tamime et al. Microbiological and technological aspects of milks fermented by bifidobacteria
CA2359334C (en) Bifidobacterium in the treatment of inflammatory disease
US4187321A (en) Method for producing foods and drinks containing bifidobacteria
CN102698258A (en) Composition and method for the treatment and prevention of enteric bacterial infections
JP4489315B2 (en) Method for producing fermented milk using egg yolk liquid containing anti-Helicobacter pylori antibody
JPS63209542A (en) Preparation of fermented milk containing bifidus bacterium
EP0432490B1 (en) Immunostimulant agent
JP3946143B2 (en) Method for producing eggs having anti-mixed bacteria immune protein
EP2953476B1 (en) Use of skim milk as a carrier for a composition comprising lactobacillus
KR100422074B1 (en) The method for production of egg containing anti-E.coli IgY and anti-Helicobacter pylori IgY and anti-Salmonella enteritidis and Salmonella typhimurium simultaneously, and egg, yolk, yogurt and ice-cream containing specific IgY for anti-E.coli and anti-Helicobacter pylori and anti-Salmonella enteritidis and anti-Salmonella typhimurium
RU2376366C2 (en) Lactis acid bacillus strains syndicate and production method of biologically active additive or leaven for production of fermented milk products based on this syndicate
JPH04330099A (en) Composition containing immunoglobulin
KR20020021545A (en) FERMENTED MILK, MILK, ICECREAM USING EGG YOLK HAVING IgY, AND ITS METHOD FOR PREPARING
Al Musa et al. Study of the chemical content and antimicrobial activity of Iraqi butter milk of cows and buffaloes
RU2090079C1 (en) Method of preparing bifidum-containing dairy product
IE990033A1 (en) Bifidobacterium longum infantis in the treatment of inflammatory bowel disease
de Lara EFFECT OF FROZEN (-196 C) AND SUBSEQUENT REFRIGERATED (5 C) STORAGE ON BETA-GALACTOSIDASE ACTIVITY, VIABILITY AND BILE RESISTANCE OF LACTOBACILLUS ACIDOPHILUS
IE20000034A1 (en) Bifidobacterium in the treatment of Inflammatory Disease
WO2009051512A1 (en) Lactobacteria strain consortium and a method for the production thereof based on a preparation used in the form of a biologically active additive or a starter for producing sour-milk products

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20041126

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20041126

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080215

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20080215

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090813

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090825

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091015

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091020

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091216

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091221

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100121

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100126

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100216

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100309

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100331

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130409

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4489315

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130409

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140409

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term